Drugs / Epigallocatechin-3-Gallate (EGCG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06068543 | Oct 2024 → Jan 2030 | — | University of Rochester | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epigallocatechin-3-Gallate (EGCG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06068543 ↗ |